The Latest
Insight
Prescription Drug Price Controls and State-Level Policymaking
Weekly Checkup
Two Lost Opportunities for Bipartisan Legislating
Insight
Comparing the Recent Drug-Pricing Reform Proposals
Weekly Checkup
Don’t Believe Everything You Read in CBO Cost Estimates
Insight
Competing Proposals to Reform Medicare Part D
Testimony
Testimony on The Lower Drug Costs Now Act (H.R. 3)
Weekly Checkup
Negotiation in Speaker Pelosi’s Drug-Pricing Proposal
Weekly Checkup
Competition and Pelosi’s Prescription Drug Plan
Insight
Senate Finance Proposes Reforms to Medicare and Medicaid Drug Policy
Weekly Checkup
The Sound and Fury on Drug Importation
Insight
How Congress Is Attempting to Lower Drug Costs
Background Research
Research
Understanding Pharmaceutical Drug Costs
Insight
Understanding the Policies that Influence the Cost of Drugs
Insight
Baseball, Arbitration, and Drug Prices
Testimony
Testimony Before the Senate Committee on Finance on Drug Pricing
Weekly Checkup
The Importance of Investment Incentives in Drug Pricing Policies
Weekly Checkup
Importing Canadian Drugs is Not the Solution to High Drug Prices
Multimedia
The AAF Exchange — Ep. 04: Drug Pricing in the U.S.
AAF’s Director of Health Care Policy Chris Holt discusses the issue of high drug prices as well as several proposed solutions for it.
Medicare Part D
Research
Redesigning Medicare Part D to Realign Incentives
Insight
Competing Proposals to Reform Medicare Part D
Insight
The Impact of Shifting Rebates to Catastrophic Coverage in Medicare Part D
Weekly Checkup
Where Does It Go From Here? Drug Pricing Policy After the Rebate Rule Reversal
Insight
What Congress Needs to Consider When Reforming Medicare Part D
Multimedia
The AAF Exchange — Ep. 09: Drug Pricing Reform
Deputy Director of Health Care Policy Tara O'Neill Hayes walks listeners through the latest reform efforts in drug pricing.
Senate Finance Proposes Reforms to Medicare and Medicaid Drug Policy
Medicare Part B
Comments for the Record
Comments To CMS On Proposed International Pricing Index for Medicare Part B Drugs
Weekly Checkup
Importing Drug Price Controls
Medicaid
Research
Primer: The Medicaid Drug Rebate Program
Weekly Checkup
Laboratories of Drug Pricing Policy
340B
Insight
CMS Moves Toward Much-Needed 340B Reforms
Research
Market Distortions Caused by the 340B Prescription Drug Program
Weekly Checkup